EGFR kinase inhibitors and gastric acid suppressants in EGFR-mutant NSCLC: a retrospective database analysis of potential drug interaction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EGFR kinase inhibitors and gastric acid suppressants in EGFR-mutant NSCLC: a retrospective database analysis of potential drug interaction

Published:2016-11-19 Issue:51 Volume:7 Page:85542-85550
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kumarakulasinghe Nesaretnam Barr¹,Syn Nicholas¹²³,Soon Yu Yang⁴,Asmat Atasha⁵,Zheng Huili⁶,Loy En Yun⁶,Pang Brendan²⁷,Soo Ross Andrew¹²

Affiliation:

1. Department of Haematology-Oncology, National University Cancer Institute, Singapore

2. Cancer Science Institute of Singapore, National University of Singapore, Singapore

3. Yong Loo Lin School of Medicine, National University of Singapore, Singapore

4. Department of Radiation Oncology, National University Cancer Institute, Singapore

5. Department of General Surgery, Tan Tock Seng Hospital, Singapore

6. National Registry of Diseases Office, Health Promotion Board, Singapore

7. Department of Pathology, National University Health System, Singapore

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton pump inhibitors decrease efficacy of palbociclib in patients with metastatic breast;Journal of Oncology Pharmacy Practice;2024-08-02

2. Do proton pump inhibitors affect the effectiveness of cyclin-dependent kinase 4/6 inhibitors in advanced HR positive, HER2 negative breast cancer? A meta-analysis;Frontiers in Pharmacology;2024-05-06

3. TPGS decorated NLC shift gefitinib from portal absorption into lymphatic delivery: Intracellular trafficking, biodistribution and bioavailability studies;Colloids and Surfaces B: Biointerfaces;2023-03

4. Evaluation of factors affecting epidermal growth factor receptor tyrosine kinase inhibitor-induced hepatotoxicity in Japanese patients with non-small cell lung cancer: a two-center retrospective study;Journal of Pharmaceutical Health Care and Sciences;2022-12-01

5. Combination Use of First-Line Afatinib and Proton-Pump Inhibitors Reduces Overall Survival Among Patients with EGFFR Mutant Lung Cancer;OncoTargets and Therapy;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3